263 related items for PubMed ID: 17593865
21. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
Tonnel AB, Bons J, Legendre M, Prud'Homme A, Bugnas B, Evano-Celli I, Stuart AM.
Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
[Abstract] [Full Text] [Related]
22.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
23.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
24. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
[Abstract] [Full Text] [Related]
25.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
26. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
Wolthers OD.
Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
[Abstract] [Full Text] [Related]
27.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
28. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG, Millar AB, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
[Abstract] [Full Text] [Related]
29. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
Leach CL, Kuehl PJ, Chand R, Ketai L, Norenberg JP, McDonald JD.
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
[Abstract] [Full Text] [Related]
30. One-year evaluation of the preventative effect of hydrofluoroalkane-beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways.
Ohbayashi H.
Respiration; 2007 Mar; 74(2):146-53. PubMed ID: 16804291
[Abstract] [Full Text] [Related]
31. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
Gross G, Thompson PJ, Chervinsky P, Vanden Burgt J.
Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
[Abstract] [Full Text] [Related]
32. Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients.
Hauber H, Taha R, Bergeron C, Migounov V, Hamid Q, Olivenstein R.
Can Respir J; 2006 Mar; 13(2):73-8. PubMed ID: 16550263
[Abstract] [Full Text] [Related]
33.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
34. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
Ohbayashi H, Adachi M.
Allergol Int; 2008 Sep; 57(3):231-9. PubMed ID: 18493166
[Abstract] [Full Text] [Related]
35. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma.
Thongngarm T, Silkoff PE, Kossack WS, Nelson HS.
J Asthma; 2005 May; 42(4):257-63. PubMed ID: 16032934
[Abstract] [Full Text] [Related]
36.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
37. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
Perruchoud AP, Lundback B, Yigla M, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
[Abstract] [Full Text] [Related]
38.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
39. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
Micheletto C, Guerriero M, Tognella S, Dal Negro RW.
Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
[Abstract] [Full Text] [Related]
40.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]